ETF Holdings Breakdown of TVTX

Stock NameTravere Therapeutics Inc
TickerTVTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS89422G1076

News associated with TVTX

Tudor Investment Corp ET AL Has $753,000 Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)
Tudor Investment Corp ET AL grew its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 13.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 43,213 shares of the company’s stock after purchasing an additional 5,069 shares […] - 2025-05-08 08:26:55
Stifel Nicolaus Issues Positive Forecast for Travere Therapeutics (NASDAQ:TVTX) Stock Price
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target increased by Stifel Nicolaus from $22.00 to $23.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a hold rating on the stock. A number of other research firms have also recently issued reports on TVTX. Guggenheim reissued a “buy” rating and […] - 2025-05-05 05:28:52
Wedbush Reaffirms “Outperform” Rating for Travere Therapeutics (NASDAQ:TVTX)
Wedbush reissued their outperform rating on shares of Travere Therapeutics (NASDAQ:TVTX – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $30.00 price objective on the stock. A number of other analysts also recently commented on TVTX. Guggenheim reiterated a “buy” rating and set a $47.00 target […] - 2025-05-05 05:28:52
XTX Topco Ltd Buys 14,928 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX)
XTX Topco Ltd grew its stake in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 105.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,133 shares of the company’s stock after acquiring an additional 14,928 shares during the period. XTX Topco […] - 2025-04-21 08:36:51
Franklin Resources Inc. Invests $631,000 in Travere Therapeutics, Inc. (NASDAQ:TVTX)
Franklin Resources Inc. purchased a new stake in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 36,238 shares of the company’s stock, valued at approximately $631,000. Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Geode Capital […] - 2025-04-17 07:38:48
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $31.00
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target increased by Bank of America from $29.00 to $31.00 in a report issued on Tuesday,Benzinga reports. Bank of America currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on the company. Citigroup increased their target […] - 2025-04-02 07:52:51
Bank of New York Mellon Corp Raises Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)
Bank of New York Mellon Corp grew its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 216,863 shares of the company’s stock after acquiring an additional 7,513 shares during the quarter. Bank of […] - 2025-03-19 07:08:45
Los Angeles Capital Management LLC Reduces Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)
Los Angeles Capital Management LLC decreased its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 42.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,996 shares of the company’s stock after selling 11,955 shares during the quarter. Los […] - 2025-03-05 10:41:21
Ieq Capital LLC Makes New Investment in Travere Therapeutics, Inc. (NASDAQ:TVTX)
Ieq Capital LLC bought a new stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 20,749 shares of the company’s stock, valued at approximately $361,000. Other hedge funds have also recently made changes to […] - 2025-02-28 09:19:05
Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Citigroup Analyst Says
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target upped by equities researchers at Citigroup from $31.00 to $35.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 69.49% from the stock’s current price. Other equities research […] - 2025-02-26 06:30:58
Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $27.77 Average Target Price from Analysts
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fourteen analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month […] - 2025-02-21 06:46:48
Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $45.00
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price hoisted by equities researchers at Canaccord Genuity Group from $22.00 to $45.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 89.71% from the stock’s […] - 2025-02-14 07:10:57
Travere Therapeutics Delivers Over 180% Gain In 6 Months
(RTTNews) - For Travere Therapeutics Inc. (TVTX), the year so far has been nothing short of remarkable, with its shares hitting new highs, driven by the success of its oral kidney disease drug, Filspari.Filspari indicated to slow kidney function decline in adults with a kidney di - 2025-02-12 10:29:03

TVTX institutional holdings

The following institutional investment holdings of TVTX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 51,915USD 1,061,143
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 9,706USD 198,391 1.0%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 42,810USD 875,036
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 42,810USD 875,036 1.0%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 252USD 5,151 1.0%
Total =147,493 USD 3,014,757
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.